Extract

P13

Risk factor and therapeutic management in patients with coronary heart disease: Results from EUROASPIRE III survey in 22 European countries

K Kotseva1, C Jennings1, G De Backer2, D De Bacquer2, D Gaita3, U Keil4, Z Reiner5, D Wood1

1  National Heart and Lung Institute, Imperial College London, London, United Kingdom, 2Ghent University, Ghent, Belgium, 3Institute of Cardiovascular Disease, Timisoara, Romania, 4Institute of Epidemiology and Social Medicine, University of Munster, Munster, Germany, 5Department of Internal Medicine, University Hospital Rebro, Zagreb, Croatia

Topic: Prevention of CVD

Aim: the aim of the third EUROASPIRE survey was to determine whether the Joint European Societies guidelines on cardiovascular disease prevention have been followed in everyday clinical practice in patients with coronary heart disease (CHD) in Europe.

Methods: the EUROASPIRE III survey was undertaken in 2006/2007 under the auspices of European Society of Cardiology, Euro Heart Survey programme in 76 centres in selected geographical areas in 22 European countries. Consecutive patients, men and women <80 years of age, with a clinical diagnosis of CHD were identified retrospectively. Data collection was based on a review of patient s medical notes and a prospective interview and examination by trained research assistants using standardised methods and instruments at least 6 months after their coronary event or procedure.

You do not currently have access to this article.

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.